RXL · ProShares Ultra Health Care ETF
ProShares Trust
$69.78
-0.36%
At close · Nov 6
Net assets $95,596,956
Holdings72
1 month
+16.11%
Year to date
+35.89%
52-week range
$42.76–$75.69
30-session avg volume
13,987
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000014253
- Report date
- Aug 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings52.25%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC67.83%
RA11.46%
DE5.18%
STIV0.32%
Country allocation
US92.15%
IE1.54%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co. | LLY | $9,669,106 | 10.11% |
| ProShares GENIUS Money Market ETF | 74350P691 | $8,510,200 | 8.90% |
| Johnson & Johnson | JNJ | $6,762,426 | 7.07% |
| AbbVie, Inc. | ABBV | $4,787,361 | 5.01% |
| Repurchase Agreement | 000000000 | $4,545,182 | 4.75% |
| Merck & Co., Inc. | MRK | $3,853,433 | 4.03% |
| UnitedHealth Group, Inc. | UNH | $3,736,389 | 3.91% |
| Repurchase Agreement | 000000000 | $3,022,189 | 3.16% |
| $2,616,177 | 2.74% | ||
| Amgen, Inc. | AMGN | $2,451,176 | 2.56% |
| Thermo Fisher Scientific, Inc. | TMO | $2,420,266 | 2.53% |
| Abbott Laboratories | ABT | $2,030,955 | 2.12% |
| Gilead Sciences, Inc. | GILD | $1,919,688 | 2.01% |
| Repurchase Agreement | 000000000 | $1,813,313 | 1.90% |
| $1,726,933 | 1.81% | ||
| Pfizer, Inc. | PFE | $1,714,004 | 1.79% |
| $1,600,000 | 1.67% | ||
| Vertex Pharmaceuticals, Inc. | VRTX | $1,460,403 | 1.53% |
| Bristol-Myers Squibb Co. | BMY | $1,441,693 | 1.51% |
| Danaher Corp. | DHR | $1,421,455 | 1.49% |
| Intuitive Surgical, Inc. | ISRG | $1,410,210 | 1.48% |
| CVS Health Corp. | CVS | $1,265,062 | 1.32% |
| Medtronic plc | $1,229,849 | 1.29% | |
| Stryker Corp. | SYK | $1,180,575 | 1.23% |
| McKesson Corp. | MCK | $1,123,471 | 1.18% |
| Repurchase Agreement | 000000000 | $967,100 | 1.01% |
| $947,371 | 0.99% | ||
| Elevance Health, Inc. | ELV | $900,879 | 0.94% |
| Regeneron Pharmaceuticals, Inc. | REGN | $845,427 | 0.88% |
| Cigna Group (The) | CI | $771,091 | 0.81% |
| Boston Scientific Corp. | BSX | $758,745 | 0.79% |
| HCA Healthcare, Inc. | HCA | $680,527 | 0.71% |
| Cencora, Inc. | COR | $665,322 | 0.70% |
| $660,102 | 0.69% | ||
| Repurchase Agreement | 000000000 | $604,438 | 0.63% |
| Cardinal Health, Inc. | CAH | $580,450 | 0.61% |
| Edwards Lifesciences Corp. | EW | $552,123 | 0.58% |
| Becton Dickinson & Co. | BDX | $547,776 | 0.57% |
| Moderna, Inc. | MRNA | $523,889 | 0.55% |
| Humana, Inc. | HUM | $485,552 | 0.51% |
| IDEXX Laboratories, Inc. | IDXX | $464,836 | 0.49% |
| IQVIA Holdings, Inc. | IQV | $461,000 | 0.48% |
| Agilent Technologies, Inc. | A | $458,684 | 0.48% |
| Veeva Systems, Inc. | VEEV | $453,390 | 0.47% |
| Waters Corp. | WAT | $431,630 | 0.45% |
| DexCom, Inc. | DXCM | $371,525 | 0.39% |
| ResMed, Inc. | RMD | $368,313 | 0.39% |
| GE HealthCare Technologies, Inc. | GEHC | $342,474 | 0.36% |
| Zoetis, Inc. | ZTS | $341,630 | 0.36% |
| Biogen, Inc. | BIIB | $337,974 | 0.35% |
Showing the top 50 of 72 holdings. Create a free account to see every holding and download the CSV.